Edwards Lifesciences Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq drops as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Stifel Reiterates Buy Rating on Edwards Lifesciences (EW)
February 12, 2025 1:46 PM ESTStifel analyst Rick Wise reiterated a Buy rating and $90.00 price target on Edwards Lifesciences (NYSE: EW).
The analyst comments "Edwards' 4Q24 performance checked all the critical boxes, including: (1) mid-single-digit TAVR growth (5.3%), despite a 12.1% 4Q23 comp and selling day headwind, suggests that TAVR growth... More
Edwards Lifesciences (EW) Tops Q4 EPS by 4c, Offers Guidance
February 11, 2025 4:17 PM ESTEdwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.59, $0.04 better than the analyst estimate of $0.55. Revenue for the quarter came in at $1.39 billion versus the consensus estimate of $1.36 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2025 EPS of $0.58-$0.64, versus the consensus of $0.59.... More
